Medtronic (NYSE:MDT) has secured a breakthrough designation from the FDA for a version of its drug-coated balloon aimed at unblocking arteries below the knee, following years of development. The In.Pact BTK catheter is slated for an international, … [Read More...] about Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
Main Content
Medical Tubing & Extrusion
Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
Medtronic (NYSE:MDT) has secured a breakthrough designation from the FDA for a version of its drug-coated balloon aimed at unblocking arteries below the knee, following years of development. The In.Pact BTK catheter is slated for an international, … [Read More...] about Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
BD’s IV catheters plant in Utah marks 70 years
BD (NYSE:BDX) is celebrating the 70th birthday of its major manufacturing facility in Utah, which the company said produces billions of molded components each year. Located in the town of Sandy just south of Salt Lake City, the site was founded in … [Read More...] about BD’s IV catheters plant in Utah marks 70 years
HighLife raises more than $90M to advance its TMVR system
HighLife (Paris) recently announced it raised €80 million (more than $90 million U.S.) for a U.S. pivotal study and expanded European commercialization of its TMVR system. The successfully completed fundraise, announced Sept. 22, was co-led by … [Read More...] about HighLife raises more than $90M to advance its TMVR system
Convatec launches new hydrophilic option for self-catheterization
Convatec is adding to its Cure family of self-administered urinary catheters, with a new model launching in the U.S. and Canada this month. The Cure Aqua is a ready-to-use intermittent catheter featuring a hydrophilic coating that the company says … [Read More...] about Convatec launches new hydrophilic option for self-catheterization
Anaconda Biomed brings in $56 million
Anaconda Biomed recently announced a $56 million funding round to advance what it describes as next-generation, novel thrombectomy catheters. The Barcelona-based company said the funds will support completion of the ongoing Athena pivotal IDE … [Read More...] about Anaconda Biomed brings in $56 million
Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
Following FDA clearance earlier this year, Perfuze is putting forward new data comparing its super-bore aspiration catheter to conventional suction methods for removing stroke-causing blood clots, as well as the emerging approach of cyclic … [Read More...] about Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
Cordis earns FDA nod for Selution SLR drug-eluting balloon
Cordis earned FDA approval for its Selution SLR (sustained limus release) drug-eluting balloon (DEB) to treat coronary in-stent restenosis, the device developer announced today. “As the first and only sirolimus drug-eluting balloon approved in the … [Read More...] about Cordis earns FDA nod for Selution SLR drug-eluting balloon
